First reported at 139,000 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2026-09-30 | 2957920 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | New | 139,000 | +139,000 (0.0%) | 2.23% | $2,957,920 | 2026-11-13 |
Who else reported the position
111 managers reported DAMORA THERAPEUTICS INC SHS (C for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| FMR LLC | New | 9,549,056 | +9,549,056 | < 0.01% | $203,203,912 | 1 qtr |
| Fairmount Funds Management LLC | New | 8,713,000 | +8,713,000 | 11.63% | $185,412,640 | 1 qtr |
| Avoro Capital Advisors LLC | New | 3,783,000 | +3,783,000 | 0.83% | $80,502,240 | 1 qtr |
| VR Adviser LLC | New | 3,603,595 | +3,603,595 | 3.73% | $76,684,502 | 1 qtr |
| BlackRock Inc | New | 3,514,573 | +3,514,573 | < 0.01% | $74,790,114 | 1 qtr |
| RA CAPITAL MANAGEMENT L P | New | 2,399,702 | +2,399,702 | 0.51% | $51,065,659 | 1 qtr |
| Remedium Capital Partners LLC | New | 2,045,473 | +2,045,473 | 15.91% | $43,527,665 | 1 qtr |
| COMMODORE CAPITAL LP | New | 1,939,000 | +1,939,000 | 3.2% | $41,261,920 | 1 qtr |
| Bellevue Group AG | New | 1,919,383 | +1,919,383 | 0.85% | $40,844,470 | 1 qtr |
| JPMorgan Chase & Co | New | 1,872,628 | +1,872,628 | < 0.01% | $38,688,495 | 1 qtr |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 13, 2026
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
- Sole
- 139,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.